333 related articles for article (PubMed ID: 28662295)
1. α9-containing nicotinic acetylcholine receptors and the modulation of pain.
Hone AJ; Servent D; McIntosh JM
Br J Pharmacol; 2018 Jun; 175(11):1915-1927. PubMed ID: 28662295
[TBL] [Abstract][Full Text] [Related]
2. α9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia.
Mohammadi S; Christie MJ
Mol Pain; 2014 Oct; 10():64. PubMed ID: 25274008
[TBL] [Abstract][Full Text] [Related]
3. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
Mohammadi SA; Christie MJ
Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047
[TBL] [Abstract][Full Text] [Related]
4. α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.
Cuny H; Yu R; Tae HS; Kompella SN; Adams DJ
Br J Pharmacol; 2018 Jun; 175(11):1855-1868. PubMed ID: 28477355
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain.
Romero HK; Christensen SB; Di Cesare Mannelli L; Gajewiak J; Ramachandra R; Elmslie KS; Vetter DE; Ghelardini C; Iadonato SP; Mercado JL; Olivera BM; McIntosh JM
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1825-E1832. PubMed ID: 28223528
[TBL] [Abstract][Full Text] [Related]
6. α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain.
Shelukhina I; Siniavin A; Kasheverov I; Ojomoko L; Tsetlin V; Utkin Y
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047495
[TBL] [Abstract][Full Text] [Related]
7. Analgesic α-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice.
Callaghan B; Adams DJ
Channels (Austin); 2010; 4(1):51-4. PubMed ID: 20368690
[TBL] [Abstract][Full Text] [Related]
8. Nicotinic acetylcholine receptors in neuropathic and inflammatory pain.
Hone AJ; McIntosh JM
FEBS Lett; 2018 Apr; 592(7):1045-1062. PubMed ID: 29030971
[TBL] [Abstract][Full Text] [Related]
9. Selective Agonists and Antagonists of α9 Versus α7 Nicotinic Acetylcholine Receptors.
Papke RL; Andleeb H; Stokes C; Quadri M; Horenstein NA
ACS Chem Neurosci; 2022 Mar; 13(5):624-637. PubMed ID: 35167270
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
[TBL] [Abstract][Full Text] [Related]
11. α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.
Mucchietto V; Fasoli F; Pucci S; Moretti M; Benfante R; Maroli A; Di Lascio S; Bolchi C; Pallavicini M; Dowell C; McIntosh M; Clementi F; Gotti C
Br J Pharmacol; 2018 Jun; 175(11):1957-1972. PubMed ID: 28726253
[TBL] [Abstract][Full Text] [Related]
12. Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.
Indurthi DC; Pera E; Kim HL; Chu C; McLeod MD; McIntosh JM; Absalom NL; Chebib M
Biochem Pharmacol; 2014 May; 89(1):131-40. PubMed ID: 24548457
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain.
Zheng N; Christensen SB; Dowell C; Purushottam L; Skalicky JJ; McIntosh JM; Chou DH
J Med Chem; 2021 Jul; 64(13):9513-9524. PubMed ID: 34161094
[TBL] [Abstract][Full Text] [Related]
14. Alpha9 nicotinic acetylcholine receptors and the treatment of pain.
McIntosh JM; Absalom N; Chebib M; Elgoyhen AB; Vincler M
Biochem Pharmacol; 2009 Oct; 78(7):693-702. PubMed ID: 19477168
[TBL] [Abstract][Full Text] [Related]
15. Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts through a Non-Opioid-Based Mechanism.
Gajewiak J; Christensen SB; Dowell C; Hararah F; Fisher F; Huynh PN; Olivera BM; McIntosh JM
J Med Chem; 2021 Jul; 64(13):9271-9278. PubMed ID: 34142837
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2) calcium channels.
Adams DJ; Berecki G
Biochim Biophys Acta; 2013 Jul; 1828(7):1619-28. PubMed ID: 23380425
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal α-conotoxins Vc1.1, AuIB and MII acting on distinct nicotinic receptor subtypes reverse signs of neuropathic pain.
Napier IA; Klimis H; Rycroft BK; Jin AH; Alewood PF; Motin L; Adams DJ; Christie MJ
Neuropharmacology; 2012 Jun; 62(7):2202-7. PubMed ID: 22306793
[TBL] [Abstract][Full Text] [Related]
18. Role of α5-containing nicotinic receptors in neuropathic pain and response to nicotine.
Xanthos DN; Beiersdorf JW; Thrun A; Ianosi B; Orr-Urtreger A; Huck S; Scholze P
Neuropharmacology; 2015 Aug; 95():37-49. PubMed ID: 25725336
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic acetylcholine receptors.
Wonnacott S; Bermudez I; Millar NS; Tzartos SJ
Br J Pharmacol; 2018 Jun; 175(11):1785-1788. PubMed ID: 29878346
[TBL] [Abstract][Full Text] [Related]
20. Understanding structure-function relationships of the human neuronal acetylcholine receptor: insights from the first crystal structures of neuronal subunits.
Giastas P; Zouridakis M; Tzartos SJ
Br J Pharmacol; 2018 Jun; 175(11):1880-1891. PubMed ID: 28452148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
